Tocqueville Asset Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-3,925
| Closed | -$383K | – | 1034 |
|
|
2015
Q1 | $383K | Hold |
3,925
| – | – | ﹤0.01% | 767 |
|
|
2014
Q4 | $364K | Sell |
3,925
-1,200
| -23% | -$111K | ﹤0.01% | 771 |
|
|
2014
Q3 | $352K | Sell |
5,125
-3,425
| -40% | -$235K | ﹤0.01% | 696 |
|
|
2014
Q2 | $896K | Buy |
8,550
+1,850
| +28% | +$194K | 0.01% | 602 |
|
|
2014
Q1 | $556K | Buy |
6,700
+2,600
| +63% | +$216K | 0.01% | 549 |
|
|
2013
Q4 | $265K | Hold |
4,100
| – | – | ﹤0.01% | 741 |
|
|
2013
Q3 | $260K | Buy |
+4,100
| New | +$260K | ﹤0.01% | 818 |
|